GE HealthCare beats on earnings, slashes full year outlook due to tariffs

GE HealthCare beats on earnings, slashes full year outlook due to tariffs

GE HealthCare reported better-than-expected first-quarter results on Wednesday, but the company slashed its annual forecast to account for the impact of President Donald Trump’s far-reaching reciprocal tariff policy. Shares of GE HealthCare were up 3% Wednesday. Here’s how the company did: Earnings per share: $1.01 adjusted vs. 91 cents expected by LSEG. Revenue: $4.78 billion … Read more

We’re exiting our position in a health-care stock to raise some cash

We’re exiting our position in a health-care stock to raise some cash

Shortly after the opening bell, we will be exiting our position in GE Healthcare , selling 550 shares at roughly $65. Following Friday’s trade, Jim Cramer’s Charitable Trust will no longer own a position in GEHC. We’re cutting loose our small position in GE Healthcare and raising some cash following two negative developments over the … Read more

We are booking profits in a rallying rotation play and buying 2 others on the dip

We are booking profits in a rallying rotation play and buying 2 others on the dip

We are making a handful of more trades Tuesday. Selling 75 shares of GE Healthcare at roughly $86 each; following the trade, Jim Cramer’s Charitable Trust will own 550 shares of GEHC, decreasing its weighting to about 1.43% from about 1.62% We are buying 50 shares of TJX at roughly $116; following the trade, the … Read more

AbbVie is the newest potential weight loss drug player

AbbVie is the newest potential weight loss drug player

A sign stands outside an Abbvie facility in Cambridge, Massachusetts. Brian Snyder | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The booming weight loss drug market has gained a new potential competitor.  AbbVie … Read more